4D Molecular Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FDMT, updated each market day.
FDMT AI Sentiment
AI predicts 4D Molecular Therapeutics, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About 4D Molecular Therapeutics, Inc. Common Stock
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Sector
Exchange
Market Cap
$502,346,632
Cap Tier
Employees
196
Headquarters
EMERYVILLE, CA
Listed Since
Dec. 11, 2020
FDMT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FDMT Volatility
4D Molecular Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
